Full Text View
Tabular View
No Study Results Posted
Related Studies
Comparison of Combination Antibiotics Eyedrop to Artificial Tear in Hordeolum After Incision and Curettage
This study is currently recruiting participants.
Verified by Chulalongkorn University, September 2007
First Received: September 21, 2007   No Changes Posted
Sponsored by: Chulalongkorn University
Information provided by: Chulalongkorn University
ClinicalTrials.gov Identifier: NCT00534391
  Purpose

To compare the effectiveness of combined antibiotic ophthalmic solution (neomycin sulfate, polymyxin B sulfate and gramicidin) with placebo (artificial tear) in the treatment of hordeolum after incision and curettage


Condition Intervention Phase
Hordeolum
Drug: neomycin sulfate, polymyxin B sulfate and gramicidin
Drug: Artificial tear
Phase III

MedlinePlus related topics: Antibiotics
Drug Information available for: Neomycin palmitate Gramicidin S Neomycin Polymyxin B Neomycin sulfate Polymyxin B Sulfate Gramicidin Neosporin
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Randomized, Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Placebo Control, Parallel Assignment, Safety/Efficacy Study
Official Title: Dose Antibiotic Need in Hordeolum After Incision and Curettage? : A Randomized, Placebo-Controlled Trial

Further study details as provided by Chulalongkorn University:

Primary Outcome Measures:
  • Pain scale [ Time Frame: 1,3,7 days after treatment ]

Secondary Outcome Measures:
  • Mass size and duration of cure [ Time Frame: 1, 3, 7, 30 days after treatment ]

Estimated Enrollment: 120
Study Start Date: September 2007
Estimated Study Completion Date: December 2008
Arms Assigned Interventions
B: Placebo Comparator
Artificial tear containing antibiotic solution base
Drug: Artificial tear
4 times daily
A: Experimental
combined antibiotic ophthalmic solution (neomycin sulfate, polymyxin B sulfate and gramicidin)
Drug: neomycin sulfate, polymyxin B sulfate and gramicidin
to the effected eye 4 times a day

Detailed Description:

Hordeolum is a common eyelid disease. In case of mass, I&C is required but role of antibiotic after I&C is not clear. It may not need in post drainage period.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • at least 5-millimeters hordeolum
  • the onset within 7 days

Exclusion Criteria:

  • previous incision and curettage of the same site within 1 month or more than 3 times
  • lesions in the adjacent areas suggesting of complications associated with hordeolum such as preseptal cellulitis or blepharitis
  • The patients with immunodeficiency, history of bleeding tendency
  • allergy to aminoglycoside, polymyxin B, gramicidin, xylocaine and povidone iodine
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00534391

Contacts
Contact: Parima Hirunwiwatkul, MD 662-2564142 ext 205 parima.H@chula.ac.th
Contact: Puangphet Chalermphanich, MD 662-2564142 ext 207 puangphet_c@yahoo.com

Locations
Thailand
Department of Ophthalmology, Chulalongkorn University Recruiting
Bangkok, Thailand, 10330
Contact: Parima Hirunwiwatkul, MD     662-2564142 ext 205     parima.H@chula.ac.th    
Contact: Puangphet Chalermphanich, MD     662-256-4142 ext 207     puangphet_c@yahoo.com    
Principal Investigator: Parima Hirunwiwatkul, MD            
Sponsors and Collaborators
Chulalongkorn University
Investigators
Principal Investigator: Parima Hirunwiwatkul, MD Department of Ophthalmology, Faculty of Medicine, Chulalongkorn University
  More Information

Publications:
Study ID Numbers: 59/50
Study First Received: September 21, 2007
Last Updated: September 21, 2007
ClinicalTrials.gov Identifier: NCT00534391     History of Changes
Health Authority: Thailand: Ethical Committee;   Thailand: Food and Drug Administration

Keywords provided by Chulalongkorn University:
Antibiotics
hordeolum

Study placed in the following topic categories:
Lacerations
Bacterial Infections
Eye Infections, Bacterial
Gramicidin
Polymyxin B
Eye Diseases
Eye Infections
Tetrahydrozoline
Hordeolum
Anti-Bacterial Agents
Anti-Infective Agents, Local
Polymyxins
Neomycin

Additional relevant MeSH terms:
Bacterial Infections
Eye Infections, Bacterial
Anti-Infective Agents
Gramicidin
Molecular Mechanisms of Pharmacological Action
Polymyxin B
Eye Diseases
Eye Infections
Enzyme Inhibitors
Infection
Hordeolum
Pharmacologic Actions
Protein Synthesis Inhibitors
Anti-Infective Agents, Local
Anti-Bacterial Agents
Therapeutic Uses
Eyelid Diseases
Neomycin

ClinicalTrials.gov processed this record on May 07, 2009